BOI:EPA
Boiron USA
18,95 €
arrow_upward
+1,34%(+0,25) 1 d.
2. nov., 16:16:28 GMT+1 · EUR
search
Visi simboli
| Simbols | Cena | Izmaiņas | % izmaiņu |
|---|
insights_autoNotiek galveno ieskatu ģenerēšana par šādu tēmu: BOI…
Atvērt
18,85 €
Augsta
19,50 €
Zema
18,70 €
Tirgus kapitalizācija
332,49 milj.
Vid. apjoms
5,37 tūkst.
Apjoms
2,37 tūkst.
Cenas/peļņas attiecība
12,56
Augstākā 52 ned.
32,25 €
Zemākā 52 ned.
16,90 €
Peļņa uz vienu akciju
1,51 €
Apgrozībā esošās akcijas
17,55 milj.
Darbinieku skaits
3 tūkst.
Atvērt
18,85 €
Augsta
19,50 €
Zema
18,70 €
Tirgus kapitalizācija
332,49 milj.
Vid. apjoms
5,37 tūkst.
Apjoms
2,37 tūkst.
Cenas/peļņas attiecība
12,56
Augstākā 52 ned.
32,25 €
Zemākā 52 ned.
16,90 €
Peļņa uz vienu akciju
1,51 €
Apgrozībā esošās akcijas
17,55 milj.
Darbinieku skaits
3 tūkst.
Ziņas un raksti
No tīmekļa avotiem un ziņu partneriem
CTech
·
pirms 13 minūtēm
XTEND lays off 10% of workforce after losing 75% of its value since $1.5 billion NYSE debut
The Joplin Globe
·
pirms 23 minūtēm
D. Boral Capital Acted as Sole Bookrunner to SPACCircle Acquisition Corp. (Nasdaq: SCQCU) in Connection with its $100,000,000 Initial Public Offering
Barchart.com
·
pirms 32 minūtēm
Trump Warns of a ‘1929-Style Economic Depression’ Ahead of the Midterms. The S&P 500 Has Risen After All 19 Midterms Since 1950.
Yahoo Finance
·
pirms 52 minūtēm
Here's How Warren Buffett's Berkshire Hathaway Stock Did in Every S&P 500 Down Year Since 2000
Profils
Boiron is a manufacturer of homeopathic products, headquartered in France and with an operating presence in 59 countries worldwide. It is the largest manufacturer of homeopathic products in the world. In 2004, it had a workforce of 2,779 and turnover of € 313 million. It is a member of the CAC Small stock index.
In June 2005, the firm acquired Dolisos Laboratories, then the world's second largest manufacturer of homeopathic preparations.
Products of Boiron include mono- and poly-preparations, which Boiron refer to as "proprietary drugs".
Homeopathy is a pseudoscience with no evidence of effectiveness for stated claims or plausible mechanism of medicinal effect, and several class action lawsuits have been filed on behalf of consumers claiming that Boiron's homeopathic products, including Children's Coldcalm and Oscillococcinum, are useless and Boiron's marketing of these products is deceptive. Wikipedia
Par “Boiron USA”
Ģenerāldirektors-
Darbinieki2,62 tūkst.
Dibināšanas datums1932. gada 7. jūn.
Galvenais birojs-
Sektors-
Tīmekļa vietneboiron.fr